Pharmaceutical Products

Share us

603139-19-1;Odanacatib;MK-0822;MK 0822;MK0822

603139-19-1;Odanacatib;MK-0822;MK 0822;MK0822

Description

Odanacatib (MK 0822) is an inhibitor of cathepsin K with potential anti-osteoporotic activity. Odanacatib selectively binds to and inhibits the activity of cathepsin K (IC50=0.2nM), which may result in a reduction in bone resorption, improvement of bone mineral density, and a reversal in osteoporotic changes. Odanacatib is currently in clinical development for the treatment of postmenopausal osteoporosis.
http://www.chemscene.com/Odanacatib.html

603139-19-1, Odanacatib;MK-0822;MK 0822;MK0822,

Read More

Previous

842133-18-0;Canagliflozin;JNJ 24831754ZAE; JNJ 284...

Previous

747412-49-3;NVP-AUY922;AUY922; VER-52296; AUY 922...

ChemScene, LLC

ChemScene Pharmaceutical chemical

Address: 11 Deer Park Drive, Suite 102A, Monmouth Junction, NJ 08852,
jersey, new jersey
United States, 07097

Tel: 732-484-9848
Fax:

H5响应式定制设计
26种语言,SEO营销型网站


H5/响应式/营销型企业网站; 26种语言扩展;
覆盖: 英文、法语、德语、西班牙语、葡萄牙语、俄语、阿拉伯语、波斯语、日语、韩语
了解更多